What is the appropriate management for pelvic congestion syndrome identified on pelvic ultrasound in a 21-year-old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Pelvic Congestion Syndrome in a 21-Year-Old Woman

For a 21-year-old woman with pelvic congestion syndrome identified on pelvic ultrasound, ovarian vein embolization is the first-line definitive treatment if she has symptomatic chronic pelvic pain, achieving approximately 75% substantial pain relief with low complication rates and sustained improvement over time 1.

Diagnostic Confirmation

Before proceeding to treatment, confirm the diagnosis with:

  • Transvaginal ultrasound criteria 2, 3:

    • Ovarian vein diameter >7-8 mm
    • Flow velocity <3 cm/s
    • Reflux duration ≥1.0 second on Valsalva maneuver
    • Myometrial vein dilatation >5 mm
    • Bilateral involvement increases diagnostic certainty
  • Venography remains the gold standard 4, 5 if ultrasound findings are equivocal or before proceeding to intervention, though recent evidence supports ultrasound-based triage to selective venography 2.

Clinical Assessment

Determine if she has symptomatic disease by asking specifically about:

  • Dull, aching pelvic pain worsened by prolonged standing
  • Post-coital pain (pathognomonic feature) 3
  • Pain relief with lying down
  • Dyspareunia
  • Premenstrual pain exacerbation
  • Vulvar or lower extremity varicosities 1

Critical caveat: Pelvic venous engorgement can exist without symptoms 5. Treatment is only indicated for symptomatic patients—imaging findings alone do not warrant intervention.

Treatment Algorithm

First-Line: Ovarian Vein Embolization

Ovarian vein embolization is the most effective treatment based on meta-analysis of 1,308 women showing 1:

  • 75% early substantial pain relief
  • Sustained improvement over 5 years 1
  • <2% risk of coil migration
  • Low repeat intervention rates
  • No documented concerns regarding menstruation, ovarian reserve, or fertility

Technical approach: Combinations of coil, glue, and sclerotherapy are used. Foam sclerotherapy with sodium tetradecyl sulfate or polidocanol can be used alone or in conjunction with embolization 1.

Additional Considerations

Internal iliac vein embolization may be added to ovarian vein embolization if there is concurrent internal iliac vein reflux, shown to be safe and effective for reducing pelvic pain 1.

Rule out compression syndromes before embolization 5:

  • Left renal vein compression (nutcracker syndrome)
  • Iliac vein compression (May-Thurner configuration)

If venous obstruction is present, treat the obstruction first before considering embolization 5. However, for isolated iliac vein compression without high-quality evidence of benefit, the 2024 consensus recommends intervention only when IVUS shows >50% area reduction or >61% diameter stenosis 6.

Alternative Treatments (Lower Evidence)

Laparoscopic ovarian vein ligation: One small study showed complete symptom resolution in 23/23 patients 1, but this requires general anesthesia and has higher morbidity than endovascular approaches.

Foam sclerotherapy alone: Effective alternative for vulvar and pudendal varicosities of pelvic origin 1.

Important Pitfalls

  1. Do not perform laparoscopy as primary diagnostic tool: CO2 pneumoperitoneum and Trendelenburg position compress pelvic veins, reducing sensitivity for PCS 3.

  2. Screen for coexisting endometriosis: PCS and endometriosis frequently coexist and share overlapping symptoms (dysmenorrhea, dyspareunia) 3. Avoid diagnostic bias by considering both conditions.

  3. Age-appropriate fertility considerations: At 21 years old, reassure that embolization has shown no documented adverse effects on fertility, menstruation, or ovarian reserve in available data 1.

  4. If initial embolization fails: Evidence is contradictory on repeat embolization effectiveness. One study suggests second procedures are unlikely to help if the first fails 1, while another showed benefit in select cases.

Expected Outcomes

  • Pain relief: 75% achieve substantial improvement 1
  • Durability: Most patients maintain relief up to 5 years 1
  • Recurrence: 30% may have mild pain recurrence at mid-term follow-up 1
  • Common transient side effect: Post-procedure pain, especially with foam embolization 1

References

Guideline

acr appropriateness criteria® lower extremity chronic venous disease.

Journal of the American College of Radiology, 2023

Research

Optimizing Venographic Referrals in Pelvic Congestion Syndrome: A Prospective Diagnostic Accuracy Study of Ultrasound-Based Scoring to Guide Selective Venography.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2026

Research

Pelvic Congestion Syndrome: The Gynecological Perspective.

Journal of clinical medicine, 2026

Research

Pelvic Congestion Syndrome.

Seminars in ultrasound, CT, and MR, 2021

Research

Imaging Appearance and Nonsurgical Management of Pelvic Venous Congestion Syndrome.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.